Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,330,423
- Total 13F value
- $1,930,752
- Share change
- +167,911
- SEC-reported price per share
- $0.30
- Number of holders
- 12
- Value change
- +$60,640
- Number of buys
- 5
- Number of sells
- 5
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
12
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
Chidozie Ugwumba
Comparable rows
13/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 177%
2 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 177%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
177%
JOHNSON & JOHNSON
134%
MMCAP International Inc. SPC
43%
MILLENNIUM MANAGEMENT LLC
17%
JANE STREET GROUP, LLC
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
177%
|
$525,278
2,813,489 shares
|
— | 31 Dec 2022 |
| JOHNSON & JOHNSON |
13F
Company
|
134%
|
$398,000
2,133,402 shares
|
— | 31 Dec 2022 |
| MMCAP International Inc. SPC |
13F
Company
|
43%
|
$127,787
684,451 shares
|
— | 31 Dec 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
17%
|
$51,000
270,848 shares
|
— | 31 Dec 2022 |
| JANE STREET GROUP, LLC |
13F
Company
|
3.8%
|
$11,159
59,768 shares
|
— | 31 Dec 2022 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.1%
|
$9,242
49,500 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
6,330,423
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
13
Q1 2023 holders
12
Holder diff
-1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend